A Vaccine for Alzheimer’s Shows Promise in Human Trial

A vaccine being tested in human patients by Dublin-based company United Neurosciences has shown promising results, according to a statement released by the company.

96 percent of patients responded to the drug and showed improved cognition and a lower level of beta-amyloid, the toxic plaque that accumulates in Alzheimer’s patients and the target of the vaccine. Read more from Being Patient. 

Leave a Comment

Get one-month FREE access to our online yoga membership site.

Sign up to our mailing list to get one month free (Value $97)

We guard your privacy and will not sell/share your personal information.
We will contact you with information related of things of interest on an occasional basis.
To read our Privacy Policy Click here